288 related articles for article (PubMed ID: 15482568)
21. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
22. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic carcinoma occurring in association with a mucinous cystic neoplasm of the pancreas.
Lane RB; Sangüeza OP
Arch Pathol Lab Med; 1997 May; 121(5):533-5. PubMed ID: 9167613
[TBL] [Abstract][Full Text] [Related]
24. Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases.
Ro JY; Sneige N; Sahin AA; Silva EG; del Junco GW; Ayala AG
Arch Pathol Lab Med; 1991 Feb; 115(2):137-40. PubMed ID: 1847035
[TBL] [Abstract][Full Text] [Related]
25. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
[TBL] [Abstract][Full Text] [Related]
26. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
Park K; Han S; Kim HJ; Kim J; Shin E
Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
[TBL] [Abstract][Full Text] [Related]
27. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin-negative primary small cell carcinoma of the breast. Report of a case and review of the literature.
Bergman S; Hoda SA; Geisinger KR; Creager AJ; Trupiano JK
Am J Clin Pathol; 2004 Jan; 121(1):117-21. PubMed ID: 14750249
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma in a solitary intraductal papilloma of the breast.
Yamaguchi R; Horii R; Maki K; Maeda I; Date Y; Nakamura T; Miyagi Y; Iwase T; Akiyama F
Pathol Int; 2009 Mar; 59(3):185-7. PubMed ID: 19261097
[TBL] [Abstract][Full Text] [Related]
30. Rare coexistence of invasive papillary carcinoma with infiltrating ductal carcinoma in male breast: report of a case.
Bhatia A; Uma Nahar Saikia ; Kumar Y
Int J Surg Pathol; 2008 Jul; 16(3):311-3. PubMed ID: 18573787
[TBL] [Abstract][Full Text] [Related]
31. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
32. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
33. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
34. Mammary endocrine ductal carcinoma in situ: a case report.
Danikas D; Matthews WE; Averbach DJ
Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
[TBL] [Abstract][Full Text] [Related]
35. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
36. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
[TBL] [Abstract][Full Text] [Related]
37. Progression of heterogeneous breast tumors.
Subramanian B; Axelrod DE
J Theor Biol; 2001 May; 210(1):107-19. PubMed ID: 11343435
[TBL] [Abstract][Full Text] [Related]
38. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers.
Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu SI
Ann Clin Lab Sci; 2006; 36(1):16-22. PubMed ID: 16501232
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic carcinoma showing rhabdoid features combined with mucinous cystadenocarcinoma of the pancreas.
Nishihara K; Katsumoto F; Kurokawa Y; Toyoshima S; Takeda S; Abe R
Arch Pathol Lab Med; 1997 Oct; 121(10):1104-7. PubMed ID: 9341593
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
